Navigation Links
Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map
Date:3/4/2011

CHAPEL HILL, N.C., March 4, 2011 /PRNewswire/ -- The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.

Facing an ever-changing launch landscape, product launch leaders are looking to guard against uncertainty as they guide new therapies through the labyrinth of regulatory and marketplace challenges.

To that end, Best Practices, LLC has collected hundreds of best practices, narratives, and metrics around the issue of new product launch. To provide launch executives with the critical information they need to succeed with a product launch, we have consolidated our best launch research and services into the Pharmaceutical Launch Excellence Services.

The Launch Excellence Services product connects launch professionals to benchmarking and networking solutions to address a variety of mission-critical issues, including:

  • Spend across launch activities
  • Differentiating a new product from competitors
  • Portfolio decisions
  • Timing and value of different new product planning activities
  • Coordinating Regional and Global launch activities
  • Strength and weakness of various structural approaches for new product planning
  • Balancing development and commercial interests
  • Brand team responsibilities
  • Use of public relations to support launch

Pharmaceutical executives will find the primary and secondary research information provided in this product essential for identifying trends, gaining a better understanding of the market and ensuring a strong market entry for new products.

To explore the Pharmaceutical Launch Excellence Services in greater detail, download our complimentary research excerpt at http://www3.best-in-class.com/or2.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For more than 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
3. Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone
4. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
5. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
6. Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
7. Savient Pharmaceuticals to Present at the 31st Annual Cowen & Co. Health Care Conference
8. Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.
9. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
10. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
11. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016  Proliant Biologicals is ... Bovine Serum Albumin (BSA) manufacturing facility.  The facility is ... Zealand , in Feilding. Boone ... done to functionally duplicate the systems in the U.S. ... vendors used for U.S. installations.  --> ...
(Date:2/11/2016)... MEMPHIS, Tenn. , Feb. 11, 2016 ... a promising new treatment method at West Cancer ... low intensity electric fields to inhibit cancer cell replication ... therapy in more than a decade to show a ... adult Glioblastoma Multiforme (GBM) patients. Currently, West Cancer Center ...
(Date:2/11/2016)... 11, 2016 PLAD, Inc. (OTC Pink: PLAD) is ... sales exceeding company targets, are adding key personnel to ... from the United States Patent and Trademark Office for ... Executive Officer of PLAD, Inc.  In January, PLAD established ... with two new customers, Cumberland Goodwill EMS ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Atlantic Information Services, ... Benefit Model: A Case Study for Plans and Purchasers.” Executives from Intel Corp. ... with Intel on value-based health benefits program Connected Care, will discuss the challenges ...
(Date:2/11/2016)... ... February 11, 2016 , ... "What holds you back from ... poses a question as a challenge for his readers to examine the full ... Being" (published by Partridge Singapore), Clarke explores the subject with more depth, revealing ...
(Date:2/11/2016)... ... February 11, 2016 , ... Greenfield ... charity program created to assist the people of their local community. The agency ... organizations and community leaders. Their hope is to bring awareness to important local ...
(Date:2/11/2016)... FRANCISCO (PRWEB) , ... February 11, 2016 , ... ... Houston-based multi-specialty practice Village Family Practice , will be presenting at the ... 2016, in Las Vegas, Nev. , During his session, “ Coding for ...
(Date:2/11/2016)... , ... February 11, 2016 , ... The annual list ... on evaluation of DataPoint’s team dedication and commitment to the SharePoint ecosystem. ... the annual list. The panel’s goal is to recognize and promote technology entrepreneurship. ...
Breaking Medicine News(10 mins):